BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29567779)

  • 1. Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ.
    Hrdinová J; Verbij FC; Kaijen PHP; Hartholt RB; van Alphen F; Lardy N; Ten Brinke A; Vanhoorelbeke K; Hindocha PJ; De Groot AS; Meijer AB; Voorberg J; Peyron I
    Haematologica; 2018 Jun; 103(6):1083-1092. PubMed ID: 29567779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells.
    Sorvillo N; van Haren SD; Kaijen PH; ten Brinke A; Fijnheer R; Meijer AB; Voorberg J
    Blood; 2013 Apr; 121(17):3502-10. PubMed ID: 23372163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
    Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
    Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADAMTS13
    Gilardin L; Delignat S; Peyron I; Ing M; Lone YC; Gangadharan B; Michard B; Kherabi Y; Sharma M; Pashov A; Latouche JB; Hamieh M; Toutirais O; Loiseau P; Galicier L; Veyradier A; Kaveri S; Maillère B; Coppo P; Lacroix-Desmazes S
    Haematologica; 2017 Nov; 102(11):1833-1841. PubMed ID: 28751567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4+ T cells from patients with acquired thrombotic thrombocytopenic purpura recognize CUB2 domain-derived peptides.
    Verbij FC; Turksma AW; de Heij F; Kaijen P; Lardy N; Fijnheer R; Sorvillo N; ten Brinke A; Voorberg J
    Blood; 2016 Mar; 127(12):1606-9. PubMed ID: 26747250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlapping ADAMTS13 peptide binding profiles of DRB1∗08:03 and DRB1∗11:01 suggest a common etiology of immune-mediated thrombotic thrombocytopenic purpura.
    Sakai K; Miyadera H; Kubo M; Nakajima F; Matsumoto M
    J Thromb Haemost; 2023 Mar; 21(3):616-628. PubMed ID: 36696200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired TTP: ADAMTS13 meets the immune system.
    Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
    Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of human leukocyte antigen DRB1-DQB1 haplotypes in the susceptibility to acquired idiopathic thrombotic thrombocytopenic purpura.
    Sinkovits G; Szilágyi Á; Farkas P; Inotai D; Szilvási A; Tordai A; Rázsó K; Réti M; Prohászka Z
    Hum Immunol; 2017 Feb; 78(2):80-87. PubMed ID: 27866840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of HLA-DQ and HLA-DP polymorphisms in cytokine responses to naturally processed HLA-DR-derived measles virus peptides.
    Ovsyannikova IG; Vierkant RA; Poland GA
    Vaccine; 2006 Jun; 24(25):5381-9. PubMed ID: 16714073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.
    Sakai K; Kuwana M; Tanaka H; Hosomichi K; Hasegawa A; Uyama H; Nishio K; Omae T; Hishizawa M; Matsui M; Iwato K; Okamoto A; Okuhiro K; Yamashita Y; Itoh M; Kumekawa H; Takezako N; Kawano N; Matsukawa T; Sano H; Ohshiro K; Hayashi K; Ueda Y; Mushino T; Ogawa Y; Yamada Y; Murata M; Matsumoto M
    Blood; 2020 Jun; 135(26):2413-2419. PubMed ID: 32253422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DQ-binding peptide motifs. 1. Comparative binding analysis of type II collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes.
    Matsushita S; Nishi T; Oiso M; Yamaoka K; Yone K; Kanai T; Nishimura Y
    Int Immunol; 1996 May; 8(5):757-64. PubMed ID: 8671664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of human leucocyte antigen DQ in the presentation of T cell epitopes in the major cow's milk allergen alphas1-casein.
    Ruiter B; Rozemuller EH; van Dijk AJ; Garssen J; Bruijnzeel-Koomen CA; Tilanus MG; Knol EF; van Hoffen E
    Int Arch Allergy Immunol; 2007; 143(2):119-26. PubMed ID: 17228168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
    Ge X; James EA; Reijonen H; Kwok WW
    J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA.
    Jucaud V
    J Immunol Res; 2017; 2017():2748614. PubMed ID: 28331856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential distribution of HLA-DQ beta/DR beta epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating polyneuropathy (AIDP): identification of DQ beta epitopes associated with susceptibility to and protection from AIDP.
    Magira EE; Papaioakim M; Nachamkin I; Asbury AK; Li CY; Ho TW; Griffin JW; McKhann GM; Monos DS
    J Immunol; 2003 Mar; 170(6):3074-80. PubMed ID: 12626563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura.
    John ML; Hitzler W; Scharrer I
    Ann Hematol; 2012 Apr; 91(4):507-10. PubMed ID: 22203269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires.
    Raddrizzani L; Sturniolo T; Guenot J; Bono E; Gallazzi F; Nagy ZA; Sinigaglia F; Hammer J
    J Immunol; 1997 Jul; 159(2):703-11. PubMed ID: 9218585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide binding predictions for HLA DR, DP and DQ molecules.
    Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
    BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.